JO
ORIC icon

John Overdeck’s Oric Pharmaceuticals ORIC Stock Holding History

John Overdeck’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Buy
+603,664
New +$5.47M ﹤0.01% 1891
2025
Q2 		– Sell
-76,990
Closed -$430K – 3433
2025
Q1 		$430K Sell
76,990
-62,693
-45% -$548K ﹤0.01% 2584
2024
Q4 		$1.13M Sell
139,683
-44,392
-24% -$407K ﹤0.01% 2100
2024
Q3 		$1.89M Sell
184,075
-78,439
-30% -$776K ﹤0.01% 1721
2024
Q2 		$1.86M Buy
262,514
+153,505
+141% +$1.37M ﹤0.01% 1602
2024
Q1 		$1.5M Buy
109,009
+3,999
+4% +$47.5K ﹤0.01% 1702
2023
Q4 		$966K Buy
105,010
+73,896
+238% +$534K ﹤0.01% 2102
2023
Q3 		$188K Sell
31,114
-75,501
-71% -$619K ﹤0.01% 2652
2023
Q2 		$827K Buy
106,615
+63,195
+146% +$359K ﹤0.01% 2057
2023
Q1 		$247K Sell
43,420
-3,149
-7% -$16.5K ﹤0.01% 2496
2022
Q4 		$274K Sell
46,569
-127,496
-73% -$430K ﹤0.01% 2276
2022
Q3 		$557K Sell
174,065
-61,271
-26% -$245K ﹤0.01% 1730
2022
Q2 		$1.05M Sell
235,336
-84,019
-26% -$335K ﹤0.01% 1522
2022
Q1 		$1.71M Buy
+319,355
New +$2.88M 0.01% 1432
2021
Q3 		– Sell
-30,641
Closed -$542K – 4573
2021
Q2 		$542K Buy
+30,641
New +$671K ﹤0.01% 3022

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

John Overdeck's ORIC Position: Q2 2026 in Review

John Overdeck opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 603,664 shares worth $6.54M. The stake represents ﹤0.01% of the portfolio and ranks #1891 among its holdings. This is a return to the name: John Overdeck previously reported a position in ORIC as recently as Q1 2025.

John Overdeck first reported a position in ORIC in Q2 2021 and has held it in 15 quarters since. 179 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • John Overdeck held 603,664 shares of Oric Pharmaceuticals worth $6.54M as of Q2 2026.
  • Oric Pharmaceuticals was a new John Overdeck position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #1891 holding.
  • John Overdeck first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • 179 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.